shortagewatch

Home / Sensory organs / Tobramycin

ATC S01AA12 · Antibiotics · updated 2 Nov 2026

Tobramycin shortage

As of 2 Nov 2026, Tobramycin has a reported shortage in 4 of the 16 countries we track (Canada, Spain, Austria, Czechia), covering 5 products from 3 companies.

Is there a Tobramycin shortage?

Yes. As of 2 Nov 2026, Tobramycin is reported short in 4 of the 16 countries we track: Canada, Spain, Austria, Czechia. The earliest expected return is 16 Nov 2026 (Czechia). 1 of 5 affected products have no return date.

Countries4/16
Products5packs or presentations
Companies31 listed
Short since10 Mar 20179.6 years ago
Earliest return16 Nov 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpain2 products shortIrelandNo reported shortageAustria1 product shortBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

CanadaSpainAustriaCzechia
20222023202420252026APO-TOBRAMYCIN (5 ML)APO-TOBRAMYCIN (5 ML)URSITAN 3 MG/ML COLIRIO EN SOLUCION EN ENVASURSITAN 3 MG/ML COLIRIO EN SOLUCION EN ENVASES UNIDOSIS , 20 envases unidosis de 0,25 mlTOBREX UNGÜENTO OFTÁLMICO 3 MG/G POMADA OFTÁTOBREX UNGÜENTO OFTÁLMICO 3 MG/G POMADA OFTÁLMICA , 1 tubo de 3,5 gTobrex Augensalbe, 3,5 gTobrex Augensalbe, 3,5 gtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Novartis3 NOVNApotex1Salvat1

Listed: Novartis NOVN · SIX Swiss

Compared with similar medicines

ATC group S01AA · Antibiotics
Tobramycin4/16Chloramphenicol3/16Combinations Of Different Antibiotics3/16Erythromycin2/16Framycetin2/16Fusidic Acid2/16Gentamicin2/16Kanamycin2/16Azithromycin1/16Netilmicin1/16

Affected products

CountryProductCompanySinceExpected backReason
CAAPO-TOBRAMYCIN (5 ML)APOTEX INC10 Mar 2017not givenManufacturing problem
Disruption of the manufacture of the drug
ESURSITAN 3 MG/ML COLIRIO EN SOLUCION EN ENVASES UNIDOSIS , 20 envases unidosis de 0,25 mlLaboratorios Salvat S.A.30 Jul 202630 Mar 2027Not stated
ESTOBREX UNGÜENTO OFTÁLMICO 3 MG/G POMADA OFTÁLMICA , 1 tubo de 3,5 gNovartis Farmaceutica S.A.6 Aug 202627 Dec 2026Not stated
ATTobrex Augensalbe, 3,5 g limitedNovartis Pharma GmbH3 Sep 20267 Dec 2026Manufacturing problem
Kapazitätsengpässe bei der Herstellung
CZTOBREX 3MG/G 3MG/G OPH UNG 3,5G anticipatedNovartis s.r.o., Praha4 Nov 202616 Nov 2026Manufacturing problem
Výrobní důvody

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Tobramycin shortage?

Yes. As of 2 Nov 2026, Tobramycin is reported short in 4 of the 16 countries we track: Canada, Spain, Austria, Czechia. The earliest expected return is 16 Nov 2026 (Czechia). 1 of 5 affected products have no return date.

When will Tobramycin be back in stock?

Companies expect supply back from 16 Nov 2026 in Czechia; Canada: no date given; Spain: 27 Dec 2026; Austria: 7 Dec 2026; Czechia: 16 Nov 2026. These are company estimates reported to each authority.

Why is Tobramycin in short supply?

The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.

Which companies have Tobramycin shortages?

Novartis, Apotex, Salvat.